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The prothoracicotropic hormone (PTTH) is an insect cerebral 
peptide that stimulates the prothoracic glands to produce 
the steroid hormone ecdysone thus initiating molting and 
metamorphosis. “Big” PTTH, one of several molecular forms 
of the neurohormone, was isolated from brains of the to- 
bacco hornworm Manduca sexta, and fractionated by high- 
pressure liquid chromatography (HPLC) for use in antibody 
production. A murine polyclonal antiserum and a monoclonal 
antibody (MAb) have been generated using this highly puri- 
fied preparation of big PTTH. Antisera and hybridoma su- 
pernatants were screened with an indirect, brain whole-mount 
immunocytological assay, and antibody specificity was con- 
firmed by immunocytological, ELISA, and functional criteria. 
In brain whole-mount preparations, the MAb (A2H5) and anti- 
serum specifically immunostained the lateral protocerebral 
neurosecretory cells (L-NSC Ill), the prothoracicotropes, 
which produce PTTH. This immunostaining was blocked by 
preadsorbing the antibodies with big PTTH. Analysis of the 
elution of HPLC-fractionated big PTTH with an in vitro bioas- 
say for the neurohormone and an ELISA employing the A2H5 
MAb resulted in peaks of activity that were superimposable. 
Finally, the antiserum and A2H5 MAb inhibited big PTTH 
activation of the prothoracic glands to synthesize ecdysone 
in the in vitro bioassay for the neurohormone. With these 
specific antibodies, the organization of the PTTH neuroen- 
docrine axis has been defined. It is now evident that both 
of the peptidergic neurons that comprise the L-NSC Ill are 
prothoracicotropes, and that the corpora allata are the neu- 
rohemal organs for the release of big PTTH into the hemo- 
lymph. This study indicates that these specific antibodies 
will be useful in investigations of numerous aspects of the 
biology of this cerebral neuroendocrine axis. 
Peptidergic neurons in the CNSs of both vertebrates and in- 
vertebrates play integral roles in the regulation of development, 
homeostasis, and reproduction (Scharrer, 1977). These neurons 
produce molecular effecters, including neurohormones, neuro- 
transmitters, and neuromodulators; conceivably, a single pep- 
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tide product could serve all of these functions (Hiikfelt et al., 
1980; Krieger, 1983). 
Vertebrate neuroendocrine axes are organizationally com- 
plex. By comparison, invertebrate neuroendocrine axes, and 
particularly those of some insects, are structurally simple, con- 
sisting of a limited number of easily identifiable neurosecretory 
cells (NSC) (Steel, 1978; Agui et al., 1979; Berlind and Maddrell, 
1979; Taghert and Truman, 1982; Tublitz and Truman, 1985; 
Copenhaver and Truman, 1986a). Thus, these invertebrate neu- 
roendocrine axes offer model systems amenable to the study of 
the fundamental properties of peptidergic neuron function. 
In the lepidopterous insect Manduca sexta, the tobacco horn- 
worm, the major cerebral neurosecretory cell groups, their ax- 
onal pathways, and their dendritic fields have been well char- 
acterized by dye-filling techniques (Nijhout, 1975; Buys and 
Gibbs, 1981; Carrow et al., 1984; Copenhaver and Truman, 
1986b). The neurohormone products of 2 of these neurosecre- 
tory cell groups have been determined. A group located dor- 
solaterally in each hemisphere of the protocerebrum, the L-NSC 
III, produces prothoracicotropic hormone (PTTH) (Agui et al., 
1979), the peptide that initiates postembryonic development by 
stimulating the prothoracic glands to produce ecdysone (see 
Bollenbacher and Granger, 1985). Five cells of a second lateral 
group, L-NSC Ia, produce eclosion hormone, which drives ec- 
dysial behaviors (Copenhaver and Truman, 1986a). While the 
cerebral neurosecretory cell groups of Manduca have been mor- 
phologically characterized, and our knowledge of the physiology 
of their functions is increasing, little is known about the bio- 
chemistry and molecular biology of the neuropeptides they pro- 
duce. The limited progress in these areas has been largely due 
to the fact that only trace quantities of neurohormones are pro- 
duced by the few neurosecretory cells in any particular group. 
Consequently, purification has been difficult and few insect neu- 
ropeptides had been sequenced (Starratt and Brown, 1975; Stone 
et al., 1976) until very recently (Cook et al., 1986; Hayes and 
Keeley, 1986; Holman et al., 1986; Nagasawa et al., 1986; Kono 
et al., 1987; Marti et al., 1987). 
Efforts to purify PTTH have spanned more than 20 years, 
but only in the past few years has substantial progress been 
made. These studies have focused principally on the silkworm, 
Bombyx mori, and Manduca sexta (see Bollenbacher and 
Granger, 1985). In these lepidopterans, PTTH appears to exist 
in multiple molecular forms that fall into 2 groups, according 
to apparent molecular weights (Bollenbacher and Gilbert, 198 1; 
Gilbert et al., 1981; Ishizaki et al., 1983; Bollenbacher et al., 
1984; Nagasawa et al., 1984; Kataoka et al., 1987). In Manduca, 
these peptides have been termed “big” (- 29 kDa) and “small” 
(-7 kDa) PTTH, with each size group consisting of additional 
variants (Bollenbacher et al., 1984). In Bombyx, the 2 classes 
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are 4.4 kDa and -22 kDa, although the 4.4 kDa variants are 
not active in Bombyx (Nagasawa et al., 1986). In contrast, big 
and small PTTHs from Munduca are active both in vivo and in 
the in vitro prothoracic gland bioassay. However, prothoracic 
glands from different developmental stages exhibit differential 
sensitivities to these PTTHs. Pupal glands are substantially more 
sensitive to big PTTH, and larval glands are equally sensitive 
to both peptides, suggesting that the PTTHs might function at 
different times during development (Bollenbacher et al., 1984). 
In Munduca. PTTH is known to be vroduced by at least one 
of the L-NSC III group (Agui et al., 1979). The axons of these 
monopolar neurons project to the contralateral cerebral lobe 
and exit the brain posteriorly via a retrocerebral nerve, the fused 
nervi corporis cardiaci I and II. This nerve innervates the glands 
of the retrocerebral complex, the corpus cardiacum plus corpus 
allatum. These are the established neurohemal organs for the 
cerebral peptidergic neurons. The L-NSC III axons traverse the 
corpora cardiaca and reach the corpora allata via the nervus 
corporis allati (Nijhout, 1975; Carrow et al., 1984; Copenhaver 
and Truman, 1986b). The axons terminate in this gland, forming 
a neurohemal organ for the release of PTTH (Agui et al., 1980; 
Carrow et al., 1984). 
of acetonitrile-water [30-50% linear gradient over 120 min, 0.2% hep- 
tafluorobutyric acid (HFBA)] at a flow rate of 0.5 ml min’. This HPLC 
separation was subsequently omitted in the preparation of immunogens 
for booster injections because it did not significantly increase the purity 
of big PTTH. At each step, PTTH activity was assessed by the in vitro 
prothoracic gland assay (see below) and expressed in units; 1 unit is the 
PTTH activity in a day 1 pupal brain (Bollenbacher et al., 1984). 
Immunization protocol. Highly purified big PTTH was vacuum-cen- 
trifuged to dryness and dissolved in 0.25 ml PBS (0.0 1 M, 0.15 M NaCl, 
pH 7.2) followed by the addition of 0.25 ml of 20% Maalox in PBS. 
The aluminum hydroxide in the Maalox forms an alum precipitate with 
the antigen (Oi and Herzenberg, 1980). A BALB/c mouse was immu- 
nized i&aperitoneally with 65;nits of big PTTH (15 pg total protein). 
Boosts of PTTH were given 1, 6, and 7 months after the initial im- 
munization (-20 units per boost, -4 pg total protein). The last boost 
was given in PBS without Maalox 3 d prior to the fusion. 
This laboratory has recently isolated several micrograms of 
highly purified big PTTH for the generation of antibodies to 
this peptide. Hybridoma technology, in combination with a 
brain whole-mount immunocytological assay to screen for an- 
tibody production, enabled the generation of big PTTH-specific 
antibodies. Both volvclonal murine antiserum and a mono- 
Blood was collected from the retrobulbar sinus of the mouse after 
each immunization, and the resulting serum (-0.1 ml/bleed) was tested 
for an immune response using the brain whole-mount immunocyto- 
logical assay (see below). 
Hybridoma production. Hybridomas were produced using standard 
procedures (Kiihler and Milstein, 1975; Galfre et al., 1977) with minor 
modifications. The myeloma cell line used for the fusions was the nonse- 
cretor P3-X63-Az8.653 (Keamev et al.. 1979). Cells were arown in 
Dulbecco’s modif;ed Eagle medium (DMEM) (Hazleton, Denier, PA), 
supplemented with 1 O-20% fetal calf serum (Gibco, Grand Island, NY), 
2 mM glutamine, 1 mM sodium pyruvate, and 0.1 mM nonessential 
amino acids (Sigma, St. Louis, MO). Spleen cells (lo*) from the re- 
sponding BALB/c mouse were fused in polyethylene glycollOO0 (Sigma) 
with myeloma cells (lo*) from a log phase culture (Pontecorvo, 1975; 
Gefter et al., 1977). The cells were diluted in the supplemented DMEM, 
which also contained 10% NCTC-109 (Gibco), 0.002 units of insulin 
(Sigma), and hypoxanthine-aminopterin-thymidine (HAT) (Hazleton), 
for selection of hvbrids (Littlefield, 1964), and were then aliquoted (0.1 
ml) into six 96-w&1 tissue culture plates (Cambridge, MA, 3595; Costar). 
Additional HAT medium (0.1 ml) was added after 24 hr and at 1 week 
the medium was changed. The cultures were incubated under 10% CO, 
at 37°C until cell growth was observed. Supematants from wells with 
hybridoma growth were screened with the whole-mount immunocy- 
clonal antibody (MAb) have been characterized by immuno- 
cytological, ELISA, and functional criteria that establish that 
they are specific for the big PTTH of Munducu. 
Materials and Methods tological assay, and positive hybridoma cells were cloned by limiting dilution (Oi and Herzenberg, 1980; Galfre and Milstein, 198 1) to yield 
Animals. Larvae of the tobacco homworm Manduca sexta were reared 
on an artificial diet (Bell and Joachim, 1976) under a nondiapausing 
photoperiod (LD 16:8) at 26°C and 60% relative humidity. Last instar 
larvae and pupae were staged at the time of ecdysis, which was desig- 
nated as day 0. 
BALB/c mice, 6-8 weeks old, were obtained from Charles River 
Laboratories (Raleigh, NC) and maintained under standard vivarium 
conditions. 
Immunogenpurijication. PTTHs were purified from day 1 pupal brains 
of Manduca by homogenization (Polytron; Brinkmann Instruments, 
Westbury, NY) in 0.5 M acetic acid, followed by centrifugation at 10,000 
x P for 15 min. The oellet was reextracted twice with acetic acid. The 
monoclonal cell lines. 
Brain whole-mount immunocytology. Antisera and hybridoma su- 
pematants were screened for antibody production with an indirect im- 
munofluorescent cytochemical assay (Coons, 1958) that employed Man- 
duca brain whole-mount preparations. Brains were dissected in Grace’s 
medium (Gibco), fixed in aqueous Bouin’s for 2 hr at room temperature, 
and rinsed overnight in PBS (0.05 M, pH 7.4) at 4°C. Following removal 
of the neurolemma, brains were permeabilized in PBS containing 2% 
Triton X-100 at 4°C. They were then incubated overnight in either 
antiserum (2% in PBS) or undiluted MAb culture medium at 4°C and 
then rinsed in PBS (3 washes) for 1 hr, followed by a 2 hr incubation 
in secondary antibody (1:20 dilution in PBS) at room temperature. 
combined supematants were heated at 100°C for 2 min and then cen- 
trifuged at l&O00 x g for 15 min. This supematant was lyophilized, 
followed bv extraction in 0.1 M acetic acid. as described above. The 
combined supematants were ultrafiltered (YM- 10; Amicon, Danvers, 
MA) to separate big PTTH (retentate) from small PTTH (eluate). The 
retentate containing big PTTH was lyophilized and resuspended in dis- 
tilled water. 
The big PTTH sample was precipitated sequentially with cold acetone 
(25, 55, and 80%) followed by centrifugation at 10,000 x g for 10 min 
after each precipitation. The 55% pellet, containing big PTTH, was 
resuspended in distilled water and subjected to reverse-phase high-pres- 
sure liquid chromatography (HPLC) on a preparative C- 18 column (7.8 
mm x 30 cm: LKB Instruments. Gaithersbura. MD) with a solvent 
system of acetonitrile+water [ 1 O-l 60% linear gradient over 90 min, 0.1% 
trifluoroacetic acid (TFA)] at a flow rate of 0.5 ml min-‘. Fractions 
containing big PTTH were pooled, vacuum-centrifuged (Speed Vat; 
Savant Instruments, Hicksville, NY), and resuspended for reverse-phase 
HPLC on an analytical C-4 column (4.6 mm x 25 cm; Vydac, Hesperia, 
CA) with a solvent system of acetonitrile-water (20-40% linear gradient 
over 60 min. 0.1% TFA) at a flow rate of 0.5 ml mini. 
mouse IgG antibodies were used with equal success (e.g., Cooper 
Various affinity-purified fhrorescein- or rhodamine-conjugated goat anti- 
Biomedical, Malvem, PA; Jackson Laboratories, West Grove, PA). The 
brains were’rinsed 3 times in PBS for a total of 2 hr, followed by a final 
rinse in distilled water. Specimens were dehydrated with ethanol (70, 
95, and lOO%, 15 min each) and then mounted in methyl salicylate. 
Fluorescence was viewed with a Nikon epifluorescence microscope. This 
protocol enabled an individual to screen 200 clones/d. 
PTTH block of cytological immunoreaqtivity. To determine whether 
the immunoreactivity in brains could be blocked with PTTH, they were 
incubated with antiserum or MAb culture medium that had been pread- 
sorbed with either bie. PTTH or control protein. Antiserum and MAb 
culture medium were-titrated for their cytological immunoreactivity to 
determine the threshold dilutions of each that would insure detection 
of any blocking with PTTH or control protein. Antiserum at a dilution 
of 1:2000 was incubated with either C-4 HPLC-purified PTTH (25 units, 
4.5 pg total protein) or a control protein mixture of ovalbumin and 
myoglobin (4.5 pg) in a 0.1 ml volume overnight at 4°C. Likewise, MAb 
culture medium at a 1:600 dilution (40 ng ml-l IgG) was incubated with 
big PTTH (30 units, 5.4 pg total protein) or control protein (5.4 pg). 
Samples of antiserum and MAb culture medium with no protein ad- 
dition were also diluted and incubated. After the overnight preincu- 
The initialimmunogen was fractionated further on a diphenyl reverse- 
phase HPLC column (4.6 mm x 25 cm; Vydac) with a solvent system 
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bation, day 1 pupal brains (3) and day 3 last instar larval brains with 
attached retrocerebral complexes (3) were incubated in each of the so- 
lutions for -24 hr at 4°C and then prepared for immunocytology. 
Enzyme-linked immunosorbent assay (ELISA). An amplified en- 
zyme-linked immunosorbent assay (ELISA) (Engvall and Perlman, 197 1) 
was performed in 96-well microtiter plates (Nunc, Roskilde, Denmark). 
Big PTTH and other antigens being tested were diluted in carbonate 
buffer (0.1 M, pH 9.6), and aliquots of each (0.1 ml) were added to wells, 
followed by a 3 hr incubation at 37°C. Wells were then washed (3 times) 
with PBS (0.01 M, pH 7.2) containing 0.1% Tween-20. MAb supema- 
tants were diluted in PBS, aliquots were added to each well (0.09 ml) 
and incubated overnight at 4°C. For competition experiments, which 
assessed the effects of increasing doses of big PTTH, small PTTH, or 
other proteins on the MAb binding to wells coated with big PTTH, the 
MAb supematant was preincubated with titrations of each of the pro- 
teins before being added to the wells. After 3 washes with PBS. an 
affinity-purified rabbit anti-mouse Ig antibody (Jackson) (22 ng ml-l in 
PBS) was added to each well (0.1 ml) and incubated for 1 hr at room 
temperature. Wells were then washed 3 times with PBS, followed by 
the addition of an alkaline phosphatase-conjugated goat anti-rabbit IgG 
antibody (1:lOOO in PBS) (Sigma) to each well (0.1 ml). After a 1 hr 
incubation, followed by 3 washes in PBS, freshly prepared substrate was 
added to each well (0.09 ml). The substrate solution consisted of p-ni- 
trophenyl phosphate disodium (0.6 mg ml-l) (Sigma) dissolved in di- 
ethanolamine buffer (1 M, 0.5 mM MgCl,, pH 9.8). The enzyme reaction 
was carried out at room temperature, and the resulting color reaction 
was spectrophotometrically quantified with a micro-ELISA reader (Dy- 
natech, Alexandria, VA). 
Isotyping and quantification of the MAbs by ELISA were essentially 
as described previously, except that wells were coated with goat anti- 
mouse immunoglobulins recognizing IgG, IgM, and IgA antibodies 
(Cooper), and incubated overnight at 4°C. After washing in PBS, known 
titers of mouse antibody standards and titrations of test antibody were 
added to the wells and incubated at 37°C for 1.5 hr. The plates were 
again washed and alkaline phosphatase-conjugated goat anti-mouse an- 
tibodies specific for the heavy chain isotypes IgG,, IgG,,, IgG,,, IgG,, 
IgM, IgA, and for kappa and lambda light chains were incubated at 
room temperature for 2 hr. Substrate was added as described above. 
In vitro prothoracic gland bioassay for PTTH. Big PTTH activity in 
HPLC column fractions was assessed and quantified with the in vitro 
prothoracic gland assay previously described (Bollenbacher et al., 1983, 
1984). One gland of each pair was incubated for 2 hr in a 0.025 ml 
standing drop of Grace’s medium containing an aliquot from a column 
fraction, and the other gland in 0.025 ml of medium only. Ecdysone 
synthesized by the glands was quantified by radioimmunoassay (macro- 
RIA) (Bollenbacher et al., 1983). The labeled ligand for the RIA was 
3H-ecdysone (New England Nuclear, Boston, MA) adjusted to 4 Ci 
mmol-I. and the unlabeled liaand was ecdvsone (a gift from Dr. D. H. 
S. Horn, CSIRO, Melbourne, Victoria, Australia). The amount of ec- 
dysone synthesized was computed using a log-logit computer program. 
Activation by big PTTH was expressed as a ratio: the amount of ec- 
dysone synthesized by the PTTH-stimulated gland divided by that syn- 
thesized by the contralateral control gland (Bollenbacher et al., 1979). 
Antibodv inhibition ofPTTH activitv in vitro. The in vitro nrothoracic 
gland assay for PTTH “was used to confirm antibody speci&ity for big 
PTTH. To demonstrate this, dose+responses of prothoracic gland ac- 
tivation were generated in the presence of 1 O/a control preimmune serum, 
test antiserum, control hybridoma culture medium, and MAb culture 
medium. Each dose of big PTTH (in 0.099 ml of Grace’s medium) was 
preadsorbed with the particular serum or medium (0.00 1 ml) overnight 
at 4°C. For these experiments, the pH of the Grace’s medium was 
adjusted from 6.2 to 6.8 to enhance antibody binding. For the assay of 
big PTTH activity, experimental glands were incubated in Grace’s me- 
dium containing the PTTH preadsorbed with 1% antibody. Control 
glands of each pair were incubated in Grace’s medium alone, because 
it was determined that neither 1% control serum nor 1% control hy- 
bridoma culture medium affected basal ecdysone synthesis or PTTH- 
stimulated ecdysone synthesis. For each dose of PTTH, activation ratios 
were computed and used to assess dose-dependent activation (Bollen- 
bather et al., 1979, 1984). In this way, dose-responses of gland acti- 
vation by PTTH in control serum and control hybridoma medium could 
be compared with dose-responses obtained with antiserum and MAb 
culture medium. Inhibition of PTTH activity by an antibody was de- 
noted by an increase in the ED,,, indicated by a shift to the right for 
the dose-response curve. Although the maximum activation ratio was 
somewhat variable, owing to the nature of the bioassay, the ED,, value 
was consistent. To minimize variability, control and experimental dose- 
responses were always run concurrently. 
Results 
Immunocytological screen for antibody production 
On the basis of previous findings that PTTH in the Manduca 
brain was localized in the L-NSC III (Agui et al., 1979) an 
immunocytological brain whole-mount assay was developed to 
screen for antibodies specific for the prothoracicotropes (Flan- 
agan et al., 1988). Pupal brains, which contain the highest level 
of PTTH activity (O’Brien et al., 1986) were used initially to 
screen serum for antibody production. Preimmune serum from 
the mouse yielded no immunoreactivity, but after an initial 
immunization, immunostaining was observed in the protho- 
racicotropes, as well as in other neurosecretory cells. After each 
boost, immunoreactivity became progressively stronger in the 
L-NSC III, but decreased in the other cells. After the final boost, 
the serum yielded immunoreactivity specific for the L-NSC III 
at a 1:2000 dilution (Fig. 1A). Since the serum was specific, had 
a high antibody titer, and yielded good immunostaining of the 
somata, axons, and dendritic processes of the prothoracico- 
tropes, it appeared that the mouse had responded to the im- 
munogen and was producing antibodies against big PTTH. 
This mouse was then used for hybridoma production, and 
hybridomas grew in 33% of the wells. Of the 200 clones screened 
with the immunocytological assay for antibody production to 
big PTTH, a single clone demonstrated strong immunostaining 
of the prothoracicotropes. The clone’s immunocytological spec- 
ificity was similar to that of the serum; however, the signal was 
stronger, with virtually no background immunofluorescence (Fig. 
2A). Clones producing antibodies specific for other neurosecre- 
tory cell groups were also identified-for example, for the large 
medial neurosecretory cells (group IIa,; Copenhaver and Tru- 
man, 1986b). All the positive primary clones were subcloned 
by limiting dilution, and rescreened and then classified for an- 
tibody isotype using the ELISA. The medial NSC-specific clone, 
designated AlCl 1, was subsequently used as a control for this 
study. 
The L-NSC III-specific clone, designated A2H5, originally 
contained both IgM and IgG, antibodies, as determined by the 
ELISA. After subcloning, the L-NSC III-specific immunoreac- 
tivity was shown to be a product of the IgG, antibody. This 
IgG,-producing hybridoma was subcloned again to insure that 
it was monoclonal. The IgG, antibody produced by the A2H5 
clone was quantified with an ELISA and was - 24 pg ml-l culture 
medium. 
Blocking of L-NSC III-specific immunoreactivity by big 
PTTH 
If the L-NSC III-specific antiserum and A2H5 MAb immu- 
noreactivities reflected antibody binding to big PTTH, then 
preadsorption of the antibodies with excess big PTTH before 
their incubation with Manduca brains should abolish the im- 
munostaining. For this study, antiserum and A2H5 MAb culture 
medium, at appropriate dilutions, were incubated either (1) alone, 
(2) with purified big PTTH, or (3) with control protein at the 
same concentration as the PTTH. Strong immunostaining of 
the L-NSC III was observed in pupal brains incubated with 
antiserum alone (Fig. 1 A) or with antiserum preincubated with 
control protein (Fig. 1B). The L-NSC III somata, axons, and 
dendritic fibers were clearly visible in both, indicating that con- 
3250 O’Brien et al. - Monoclonal Antibody and PTTH 
Figure 1. Photomicrographs of the 
neurosecretory cell specificity of the 
murine antiserum in day 1 pupal brain 
whole-mounts of Ma&ca~&xta. The 
immunofluorescent staining is specific 
for the L-NSC III, the prothoracico- 
tropes (A). The L-NSC III immuno- 
staining is not blocked by preincubat- 
ing the antiserum with control protein 
(B), but is partially blocked by prein- 
cubation with big PTTH (C). Scale bar, 
100 Km. 
trol protein did not affect the specific staining. However, prein- 
cubation of the antiserum with big PTTH resulted in a sub- 
stantial decrease in immunoreactivity (Fig. 1 C). The axons and 
dendritic processes of the L-NSC III were not visible and the 
somata were only faintly immunoreactive. Big PTTH thus par- 
tially blocked the antiserum’s L-NSC III-specific immunostain- 
ing. The inability to block the immunoreactivity completely was 
probably due to the limited amount of big PTTH available for 
preadsorption and to the range of avidities of antibodies present 
in the serum. However, the presence of antibodies specific for 
other components of the L-NSC III cannot be ruled out as a 
possible reason for this faint immunostaining. 
Using the A2H5 MAb, pupal brains (Fig. 2A) and day 3 last 
larval instar corpora allata (Fig. 2B) were specifically immu- 
nostained. This immunostaining was confined to the L-NSC III 
somata, their axons, dendritic fibers, and terminal endings in 
the corpora allata. Preincubation of the A2H5 MAb with control 
protein did not affect the L-NSC III-specific immunoreactivity 
in either the brain (Fig. 2C) or corpora allata (Fig. 20). However, 
the immunoreactivity of the A2H5 MAb was blocked com- 
pletely following preadsorption with big PTTH. There was no 
immunostaining in the brain, nerves, or corpora allata (Fig. 2, 
E, F). The arrows in Figure 2 denote the immunoreactivity in 
the axons in the nervus corporis allati, which connects the cor- 
pora cardiaca to the corpora allata (Fig. 2, B, D), and the com- 
plete loss of this immunoreactivity after preadsorption with big 
PTTH (Fig. 2F). Thus, the A2H5 MAb and antiserum cytolog- 
ical immunoreactivity appeared to reflect the presence of an- 
tibodies directed against big PTTH. 
HPLUELISA assessment of antibody specificity 
An amplified ELISA was developed for use in conjunction with 
HPLC of big PTTH to characterize the A2H5 MAb antigen 
specificity. Antiserum was not used in this study because it 
generally resulted in high backgrounds in the ELISA. First, the 
specificity of the assay was defined by testing the A2H5 MAb 
for immunobinding to big PTTH, Manduca small PTTH (Bol- 
lenbacher et al., 1984), bovine insulin, ovalbumin, and myo- 
globin. The AlCl 1 medial NSC-specific MAb was used as a 
control antibody in this study. The A2H5 MAb was specific for 
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F&WV 2. Photomicrographs of the neurosecretory cell specificity of the A2H5 MAb in whole-mounts of day 1 pupal brains and day 3 last larval 
instar corpora allata of Munducu. The immunofluorescent staining is specific for the L-NSC III (A) and their terminals in the corpora allata (B). 
The L-NSC III immunostaining in the brain (C) and corpora allata (0) is not blocked by preincubating the A2H5 MAb with control protein, but 
is completely blocked in the brain Q and corpora allata Q by preincubation with big PTTH. Arrows denote the L-NSC III axons in the nervus 
corporis allati. 
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Figure 3. Specificity of the A2H5 MAb for big PTTH in the ELISA. 
Big PTTH (0.5 units, 0.1 pg of protein), small PTTH (0.5 units, 1 pg 
of protein), bovine insulin (0.1 pg), ovalbumin (0.1 rg), and myoglobin 
(0.1 pg) were each assayed in duplicate; the absorbance is the average 
of the 2. Small PTTH was only partially purified, hence the higher 
protein concentration. The medial cell-specific AlCl 1 MAb was used 
as a control antibody in the ELISA. Small PTTH was also tested at 0.1 
pg of protein (not shown) and the results were the same. 
Figure 4. Elution profile of big PTTH 
from a C-4 reverse-phase HPLC frac- 
tionation assessed by ELISA (0) and 
the in vitro prothoracic gland bioassay 
(bars). Dottedline, the acetonitrilewater 
gradient employed, inset, the protein 
elution profile for the separation. 
big PTTH (Fig. 3), exhibiting no cross-reactivity with the other 
proteins, and the A 1 C 11 MAb did not cross-react with big PTTH 
or any of the other proteins. Thus, using the A2H5 MAb in the 
ELISA was suitable for a chromatographic characterization of 
the antigen specificity of the antibody. 
A reverse-phase C- 18 HPLC-fractionated preparation of big 
PTTH was separated on HPLC using an analytical reverse-phase 
C-4 column. The elution of big PTTH was assessed by both 
ELISA and the in vitro prothoracic gland bioassay (Fig. 4). In 
both assays, activity was detected in fractions 59-64. The peak 
of activity with the ELISA (absorbance, 1.045) occurred at frac- 
tion 62; this corresponded precisely with the fraction repre- 
senting the peak of biological activity (activation ratio, 6.3). The 
protein elution profile for this separation (Fig. 4, inset) revealed 
a sharp peak of absorbance at this same fraction. 
Together, these ELISA and bioassay results provided addi- 
tional evidence that the A2H5 MAb is directed against big PTTH 
in its native, biologically active configuration. In addition, the 
precise agreement between the ELISA and bioassay data indi- 
cated that the A2H5 MAb could be used in the ELISA to mon- 
itor the purification of big PTTH. 
The impure state of the small PTTH used in the ELISA to 
determine the specificity of the A2H5 MAb may have precluded 
binding to the microtiter wells, and consequently detection of 
any cross-reactivity. To better assess cross-reactivity with small 
PTTH, a competition ELISA was employed. This approach is 
less dependent on the purity of the hormone. The A2H5 MAb, 
preincubated with increasing doses of either big PTTH, small 
PTTH, or control protein, was added to microtiter wells pre- 
viously coated with 0.5 units of big PTTH. Unbound big PTTH, 
from 0.3 to 5.0 units, caused a sharp decrease in the ELISA 
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Figure 5. Assessment of the cross-reactivity of small PTTH with the 
A2H5 MAb by a competition ELISA. The A2H5 MAb was preincubated 
with increasing units ofbig PTTH (0) and small PTTH (0) before testing 
in the ELISA. Each datum point represents the average of 2 absorbance 
determinations expressed as the percentage of maximal binding (ab- 
sorbance resulting from the A2H5 MAb incubated alone). 
response, from 100% of maximal binding to 3% (Fig. 5). Equiv- 
alent doses of small PTTH resulted in a gradual decrease in the 
ELISA response, from 100% to 67% of maximal binding (Fig. 
5). Since the small PTTH extract has approximately 10 times 
more protein than the equivalent units of big PTTH, increasing 
doses of a control protein (myoglobin) at the same protein con- 
centration as the small PTTH extract were also assessed in the 
competition ELISA. Myoglobin at the highest dose (9 pg well-‘) 
decreased the A2H5 MAb ELISA response to 86% of maximal 
binding. It appears that high levels of control protein slightly 
inhibit the A2H5 MAb binding to big PTTH adsorbed to mi- 
crotiter wells. The results suggest hat if the A2H5 MAb does 
recognize small PTTH, the epitope is not identical to that of 
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Figure 6. Effect of the murine antiserum on the dose-response of day 
0 pupal prothoracic gland activation by big PTTH. The control dose- 
response was generated with big PTTH preincubated with preimmune 
serum (O), and the experimental with big PTTH preincubated with 
antiserum (0). Each datum point represents the mean + SEM of 3 
determinations. 
PTTH, units 
Figure 7. Effect of the A2H5 MAb on the dos+response of day 0 pupal 
prothoracic gland activation by big PTTH. A, Dose-responses of acti- 
vation obtained with big PTTH preincubated with control hybridoma 
medium (0) and A2H5 MAb medium (0). B, Dose-responses of acti- 
vation obtained with big PTTH preincubated with AlCl 1 MAb me- 
dium (0) and A2H5 MAb medium (0). Each datum point represents 
the mean f  SEM of 3 determinations. 
Antibody inhibition of PTTH activity in vitro 
While the immunocytological and ELISNHPLC studies pro- 
vided convincing evidence that the antiserum and A2H5 MAb 
were directed against big PTTH, conclusive proof required the 
demonstration of antibody inhibition of the neurohormone’s 
biological activity. This was shown by assessing the effect of the 
antibodies on big PTTH’s dose-dependent activation of the pro- 
thoracic glands. This approach was possible since 1% control 
preimmune serum or control hybridoma culture medium did 
not affect basal or PTTH-stimulated ecdysone synthesis by the 
prothoracic glands (results not shown). The dose-response of 
prothoracic gland activation by big PTTH preincubated with 
preimmune serum (Fig. 6) demonstrated the typical stimulation 
of the glands (Bollenbacher et al., 1983, 1984). Gland activity 
increased from a basal activation ratio of 1 at 0.02 units of big 
PTTH to a maximum activation ratio of 4.5 at 0.1 units. A 
concurrent dose-response analysis of big PTTH preincubated 
with antiserum (Fig. 6) revealed a significant decrease in gland 
stimulation. Here, a dose of big PTTH as high as 0.1 units did 
not elevate gland activity above a basal level, and at 0.25 units, 
the activation ratio was only 2.5. Quantification (ED,, analysis) 
of PTTH activity from these dose-response curves (Bollen- 
bather et al., 1979, 1984) revealed that the antiserum had in- 
hibited -85% of the big PTTH activity. 
A similar dose-response analysis of big PTTH preincubated 
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Figure 8. Photomicrographs of the A2H5 MAb immunofluorescent staining of the entire prothoracicotrope neuroendocrine axis in whole-mounts 
of day 1 pupa&brain-retrocerebral complexes of Manducu. Immunostaining depicts the complete morphology of the big PTTH axis (A), the 
prothoracicotrope somata with proximal dendritic processes (B), decussation of the primary axons with descending medial dendritic processes (c), 
and the terminal arborizations in the corpora allata (D). Scale bars, 50 pm. 
with control hybridoma medium resulted in normal activation 
of the prothoracic glands (Fig. 7A). The response increased from 
a basal activation ratio of 1 at 0.02 units of big PTTH to 5 at 
0.25 units. A concurrent dose-response analysis of big PTTH 
preincubated with the A2H5 MAb resulted in no detectable 
activation of the glands (Fig. 7A), indicating that the antibody 
had inhibited all of the neurohormone’s activity. 
To insure that the apparent inhibition of big PTTH activity 
by the A2H5 MAb was specific, an additional dose-response 
was generated using PTTH preincubated with the A 1 Cl 1 MAb. 
Activation of the glands by big PTTH was normal (Fig. 7B), 
increasing from a basal activation ratio of 1 at 0.02 units to an 
activation ratio of 3.5 at 0.25 units of PTTH. The concurrent 
dose-response analysis of big PTTH preincubated with the A2H5 
MAb yielded the expected lack of gland stimulation, indicative 
of complete inhibition of PTTH activity (Fig. 79. Therefore, 
the A2H5 MAb and murine serum antibodies raised against big 
PTTH are directed against the neurohormone. Since the anti- 
bodies inhibited big PTTH activity directly, it appears that the 
epitope they are binding to is near, or perhaps part of, the active 
site of the hormone. 
Immunocytological characterization of the prothoracicotrope 
A precise immunocytological characterization of the cellular 
distribution of big PTTH in the L-NSC III was now feasible, 
using the big PTTH A2H5 MAb. Employing the whole-mount 
protocol, the brain and attached retrocerebral complexes were 
immunostained to illustrate the complete morphology of the 
big PTTH axis (Fig. 8A). In this preparation, all of the L-NSC 
III were immunostained, and at a higher magnification, details 
of the various morphological components of these peptidergic 
neurons were clearly discernible (Fig. 8, B-D). A significant 
finding was that all 4 of the L-NSC III were equally immuno- 
reactive, indicating that both cells of the L-NSC III pair are 
prothoracicotropes (Fig. 8B). 
The axons of these monopolar neurons traverse medially 
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through the protocerebrum to the contralateral lobe (Fig. 8C) 
and then posteriorly, exiting the brain via the nervi corporis 
cardiaci I + II (Fig. 8A). They then pass through the corpora 
cardiaca without branching, and finally pass through the nervus 
corporis allati before terminating in the corpora allata. In the 
corpora allata, the axon terminals form numerous varicosities 
characteristic of a neurohemal organ, i.e., a release site for a 
neurohormone (Fig. 80). This finding supports the idea that the 
corpus allatum is the release site for big PTTH synthesized by 
the L-NSC III (Agui et al., 1980). 
Last, the immunocytological staining revealed that big PTTH 
is present in many dendritic fibers of the L-NSC III that project 
into the protocerebral neuropil (Fig. 8, B, C). The principal 
dendritic arborizations were observed in the dorsal region of 
the protocerebrum, near the somata (Fig. 8B), and in a region 
that extends posteriorly along the midline toward the tritocere- 
brum in the cerebral hemispheres (Fig. SC). 
Discussion 
A murine polyclonal antiserum and a MAb to the big PTTH of 
Manduca sexta have been produced. By immunocytological, 
chromatographic, and functional criteria, the antibodies are ex- 
tremely specific. The antibodies recognize the native configu- 
ration of the neurohormone, as demonstrated by their capacity 
to inhibit the biological activity of big PTTH in the in vitro 
prothoracic gland assay. In this assay, it was not necessary to 
immunoprecipitate big PTTH to detect binding. This suggests 
that the A2H5 MAb and serum antibodies are binding to an 
epitope that is part of or near the active site of big PTTH for 
binding to a receptor. Thus, these antibodies to big PTTH should 
be very useful probes for investigating the biology of the PTTH 
neuroendocrine axis in Manduca. 
A detailed immunocytological characterization of the PTTH 
neuroendocrine axis with the A2H5 MAb indicated that both 
L-NSC III were prothoracicotropes. This finding necessitates a 
reconsideration of the original identification of the neurosecre- 
tory cells that produce PTTH. It had been reported previously 
that only one of the cells of the L-NSC III pair was a protho- 
racicotrope (Agui et al., 1979) a conclusion based on the amount 
of PTTH biological activity present in individual, isolated L-NSC 
III somata. By contrast, the A2H5 MAb has clearly demon- 
strated that both of the L-NSC III contain an epitope that is 
part of big PTTH. The discrepancy between the results of these 
2 studies may be attributed to the low amount of PTTH activity 
present in an individual L-NSC III soma and the sensitivity of 
the bioassay employed to detect this activity. In the earlier study, 
one soma clearly possessed a significant amount of PTTH ac- 
tivity, while the other possessed activity only slightly above 
background. The difficulty associated with manipulating indi- 
vidual NSC somata for activity assay may have resulted in the 
loss of some PTTH activity from one of the cells. Alternatively, 
immunocytological analysis is a direct and sensitive means of 
denoting the presence of big PTTH in cells; thus, it now appears 
that both of the L-NSC III are the prothoracicotropes. 
The immunocytological localization of big PTTH within the 
L-NSC III has also provided a more precise determination of 
the site of big PTTH release. Retrograde and anterograde dye- 
fills of the L-NSC III revealed that their axons terminate in the 
corpora allata (Nijhout, 1975; Carrow et al., 1984; Copenhaver 
and Truman, 1986b). These results, combined with the finding 
that the corpora allata contains far more PTTH activity than 
does the corpora cardiaca (Agui et al., 1980) led to the conclu- 
sion that the corpora allata were the neurohemal organs for the 
Manduca prothoracicotropes. Nevertheless, it was suggested that 
the corpora cardiaca were also release sites for PTTH (Carrow 
et al., 198 l), a conclusion based on the apparent in vitro release 
of PTTH from the corpora cardiaca. The immunocytological 
results have revealed that the big PTTH-containing axons tra- 
verse the corpora cardiaca without branching, then terminate 
and arborize exclusively in the corpora allata. Thus, it appears 
that the corpora allata are the only neurohemal organs for big 
PTTH release into the hemolymph. It is possible that the PTTH 
activity released from the corpora cardiaca in vitro (Carrow et 
al., 198 1) may represent small PTTH. To date, the NSC that 
synthesize this peptide and its site of release have not been 
established. The fact that the corpora cardiaca-associated PTTH 
activity was assessed with a larval prothoracic gland bioassay, 
which is much more sensitive to small PTTH than the pupal 
gland assay (Bollenbacher et al., 1984), further supports this 
possibility. Alternatively, the PTTH activity apparently released 
from the corpora cardiaca may be a nonphysiological event 
caused by the in vitro conditions that reflect PTTH leakage from 
the L-NSC III axons as they pass through the corpora cardiaca. 
One intriguing finding of the immunocytological studies with 
the A2H5 MAb was the presence of big PTTH in the dendritic 
processes of these neurosecretory cells. It has generally been 
assumed that the dendritic fields of the cerebral neurosecretory 
cells of insects represent sites of afferent synaptic input for the 
control of these peptidergic neurons (Bern, 1962), but efferent 
output of neurosecretory material from these collaterals has also 
been suggested (Schooneveld, 1974). Additionally, it has been 
proposed that, in insects, these projections serve as a reservoir 
for neurosecretory material (Highnam and West, 197 1). In Man- 
duca, big PTTH is present in these processes in fairly high 
amounts, as indicated not only by strong cytological immuno- 
reactivity, but also by measurements of PTTH activity in dif- 
ferent regions of the protocerebrum (Agui et al., 1979). It is 
possible that these fibers are storage sites for the hormone, but 
they appear to possess terminal-like swellings containing PTTH, 
suggesting that the peptide may be released to act locally within 
the brain. A more thorough immunohistochemical analysis of 
these areas of the protocerebral neuropil at an ultrastructural 
level will be necessary to determine whether big PTTH is present 
in presynaptic terminals. The presence of PTTH in such ter- 
minals would support the idea that it is acting locally within 
the brain in a neuromodulator and/or neurotransmitter capac- 
ity. An analysis of the dendritic fibers of the different neurose- 
cretory cell groups in Manduca indicates that they overlap con- 
siderably, forming a neurosecretory neuropil (Copenhaver and 
Truman, 1986b), and thus providing an anatomical basis for 
possible intercommunication (Taghert, 198 1). If big PTTH ter- 
minals exist in the protocerebrum, perhaps intercommunication 
between neurosecretory cells can be direct via big PTTH, func- 
tioning as a neuromodulator or neurotransmitter. The evolving 
realization that many neurohormones act as neurotransmitters 
or neuromodulators in the CNS of both vertebrates and inver- 
tebrates (see Joosse, 1986) lends support to this hypothesis. 
The A2H5 MAb has proven sufficiently specific for big PTTH 
to be used in an ELISA for the neurohormone. The PTTH- 
ELISA is currently being employed to monitor the purification 
of big PTTH, thus circumventing the use of the lengthy and 
comparatively tedious in vitro prothoracic gland assay for the 
neurohormone. Given the usefulness of the A2H5 MAb in the 
ELISA, it is anticipated that it can be employed in other assays 
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(e.g., RIA) suitable for quantifying the hormone. The specificity 
of the A2H5 MAb should also permit affinity-purification of big 
PTTH. 
The cross-reactivity of small PTTH with the A2H5 MAb, 
assessed by a competition ELISA, indicated that this antibody 
would not be suitable for affinity-purification of small PTTH. 
Cross-reactivity was minimal, although the small PTTH extract 
caused a slight decrease in the percentage of maximal binding. 
It is possible that this effect is due to a related epitope on the 
small PTTH molecule, although the results are not conclusive. 
If, indeed, the A2H5 MAb is recognizing the receptor binding 
site of big PTTH, then perhaps weak cross-reactivity with small 
PTTH is a result of a lower affinity for a similar, but not iden- 
tical, receptor binding site. Additional studies on this binding, 
e.g., antibody inhibition of the biological activity of small PTTH, 
will be necessary to resolve the issue of the structural relation- 
ship between big and small PTTH. 
Recently, a MAb has been produced to a synthetic fragment 
of the cerebral insulin-like 4 kDa peptide from Bombyx mori, 
bombyxin, which has PTTH-like activity in another lepidop- 
teran, Samia Cynthia ricini (Suzuki, 1986; Mizoguchi et al., 
1987). Although this MAb does not recognize the native peptide, 
it does bind to the medial NSC of the Bombyx brain. It is 
possible that this peptide is analogous to the small PTTH in 
Manduca; thus the Manduca small PTTH may be produced by 
medial neurosecretory cells. Interestingly, the initial immuni- 
zation with big PTTH yielded serum that gave weak immu- 
nostaining of the medial NSC in Manduca brains. This staining 
could be due to serum antibodies binding to a peptide struc- 
turally related to big PTTH, possibly small PTTH. Altema- 
tively, the medial NSC immunoreactivity could be a result of 
a contaminant in the big PTTH antigen localized in these cells. 
Determining the specificity of the medial NSC-specific mono- 
clonal antibody (AlCl 1) derived from this mouse will be es- 
pecially interesting in light of the localization of bombyxin. 
It is equally likely that 22K-PTTH in Bombyx (Kataoka et 
al., 1987) may be produced by lateral cerebral neurosecretory 
cells. If this is the case, these MAbs could be used to investigate 
possible functional/structural relationships between the big and 
small PTTHs of these 2 lepidopterans. Additional phylogenetic 
studies in nonlepidopterans are being conducted currently. Pre- 
liminary immunocytological studies using the big PTTH anti- 
serum suggest hat lateral NSC in other species produce PTTH. 
However, this cross-reactivity has not been observed using the 
A2H5 MAb. The possibility that the epitope recognized by the 
A2H5 MAb is unique to Manduca is being investigated. 
The regulatory mechanisms underlying the differentiation and 
expression of neuronal phenotypes is an important area of neu- 
robiological research (Purves and Lichtman, 1985). The poten- 
tial of the A2H5 MAb for investigating expression of a pepti- 
dergic phenotype in a small subset of neurons in a developmental 
context is apparent. In fact, preliminary ontogenetic studies in 
Manduca have revealed that big PTTH is detectable immu- 
nocytologically as early as at 30% of embryogenesis (A. West- 
brook and W. E. Bollenbacher, unpublished observations). These 
results have been supported by measurements of PTTH activity 
in Manduca embryos at this stage (Dom et al., 1987). Addi- 
tionally, PTTH activity has also been found in Bombyx embryos 
(Chen et al., 1987; Fugo et al., 1987). The presence of the neu- 
rohormone in the embryonic brain suggests that it may have an 
endocrine function, perhaps to elicit increases in the ecdysteroid 
titer that may drive embryonic molting late in embryogenesis 
(see Hoffmann and Lagueux, 1985; Dom et al., 1987). The big 
PTTH A2H5 MAb could be employed to investigate the reg- 
ulation of expression of a peptidergic phenotype at the level of 
individual cells, as well as the functional role of a neuropeptide 
in embryogenesis. 
In summary, a MAb and antiserum to the big PTTH of Man- 
duca sexta have been generated, and they appear to have prop- 
erties that should enable their use in an array of studies on the 
biology of the PTTH neuroendocrine axis in insects. This pep- 
tidergic system, confined to 4 large neurosecretory cells in the 
brain of an insect, should be very useful for investigating fun- 
damental developmental and functional properties of pepti- 
dergic neurons. 
References 
Agui, N., N. A. Granger, L. I. Gilbert, and W. E. Bollenbacher (1979) 
Cellular localization ofthe insect prothoracicotropic hormone: In vitro 
assay of a single neurosecretory cell. Proc. Natl. Acad. Sci. USA 76: 
5694-5698. 
Agui, N., W. E. Bollenbacher, N. A. Granger, and L. I. Gilbert (1980) 
Corpus allatum is release site for insect prothoracicotropic hormone. 
Nature 285: 669-670. 
Bell, R. A., and F. G. Joachim (1976) Techniques for rearing labo- 
ratory colonies of tobacco hornworms and pink bollwomrs. Ann. 
Entomol. Sot. Am. 69: 365-373. 
Berlind, A., and S. H. P. Maddrell (1979) Changes in hormone activity 
of single neurosecretory cell bodies during a physiological secretion 
cycle. Brain Res. 161: 459467. 
Bern, H. A. (1962) The properties of neurosecretory cells. Gen. Comp. 
Endocrinol. (Suppl.) 1: 117-l 32. 
Bollenbacher, W.E., and L. I. Gilbert (1981) Neuroendocrine control 
of postembryonic development in insects: The prothoracicotropic 
hormone. In Neurosecretion: Molecules, Cells, Systems, D. S. Famer 
and K. Lederis, eds., pp. 361-379, Plenum, New York. 
Bollenbacher, W. E., and N. A. Granger (1985) Endocrinology of the 
prothoracicotropic hormone. In Comprehensive Insect Ph&iology, 
Biochemistrv and Pharmacoloav. vol. 7. G. A. Kerkut and L. I. Gil- 
bert, eds., pp. 109-151, Pergamcn, New York. 
Bollenbacher, W. E., N. Agui, N. A. Granger, and L. I. Gilbert (1979) 
In vitro activation of insect prothoracic glands by the prothoracico- 
tropic hormone. Proc. Natl. Acad. Sci. USA 76: 5 148-5 152. 
Bollenbacher, W. E., M. A. O’Brien, E. J. Katahira, and L. I. Gilbert 
(1983) A kinetic analysis of the action ofthe insect prothoracicotropic 
hormone. Mol. Cell. Endocrinol. 32: 27-46. 
Bollenbacher, W. E., E. J. Katahira, M. A. O’Brien, L. I. Gilbert, M. 
K. Thomas, N. Agui, and A. H. Baumhover (1984) Insect pro- 
thoracicotropic hormone: Evidence for two molecular forms. Science 
224:1243-1245. 
Buys, C. M., and D. Gibbs (198 1) The anatomy of neurons projecting 
to the corpus cardiacum from the larval brain of the tobacco hom- 
worm, M&duca sexta (L.). Cell Tissue Res. 215: 505-5 13. 
Carrow. G. M.. R. L. Calabrese. and C. M. Williams (1981) Snonta- 
neous and evoked release of prothoracicotropin from muhiple neu- 
rohemal organs of the tobacco homworm. Proc. Natl. Acad. Sci. USA 
78:5866-5870. 
Carrow, G. M., R. L.. Calabrese, and C. M. Williams (1984) Archi- 
tecture and physiology of insect cerebral neurosecretory cells. J. Neu- 
rosci. 4: 1034-1044. 
Chen, J. H., H. Fugo, M. Nakajima, H. Nagasawa, nd A. Suzuki (1987) 
Neurohormones in developing embryos of the silkworm, Bombyx 
mori: The presence and characteristics of prothoracicotropic her- 
mone-B. J. Insect Phvsiol. 33: 407-4 11. 
Cook, B. J., G. M. Ho&an, and R. J. Nachman (1986) Comparative 
actions of a new series of myotropic peptides on the visceral muscles 
of an insect. In Znsect Neurochemistry and Neurophysiology, A. B. 
Bofkovec and D. B. Gelman, eds., pp. 199-202, Humana, Clifton, 
NJ. 
Coons, A. H. (1958) Fluorescent antibody methods. In General Cy- 
tochemicalMethods, vol. 1, J. F. Danielli, ed., pp. 3991122, Academ- 
ic, New York. 
Copenhaver, P. F., and J. W. Truman (1986a) Identification of the 
The Journal of Neuroscience, September 1988, B(9) 3257 
cerebral neurosecretory cells that contain eclosion hormone in the 
moth Munduca sexta. J. Neurosci. 5: 1738-1747. 
Copenhaver, P. F., and J. W. Truman (1986b) Metamorphosis of the 
cerebral neurosecretory system in the moth Munducu sexta. J. Comp. 
Neurol. 249: 186-204. 
Dom, A., L. I. Gilbert, and W. L Bollenbacher (1987) Prothoraci- 
cotropic hormone activity in the embryonic brain of the tobacco 
homworm, Munducu sextu. J. Comp. Physiol. B 157: 279-283. 
Engvall, E., and P. Perlmann (197 1) Enzyme-linked immunosorbent 
assay (ELISA): Quantitative assay of immunoglobulin G. Immuno- 
chemistry 8: 87 l-874. 
Flanagan, T. R., K. Tomioka, M. A. O’Brien, A. L. Westbrook, N. Agui, 
and W. E. Bollenbacher (1988) Neuroendocrine regulation of insect 
development. In Proceedings of the Beltsville Symposium XZZ, Kluver 
Academic Press (in press). 
Fugo, H., J. H. Chen, M. Nakajima, H. Nagasawa, and A. Suzuki (1987) 
Neurohormones in developing embryos of the silkworm, Bombyx 
mori: The presence and characteristics of prothoracicotropic hor- 
mone-S. J. Insect Physiol. 33: 243-248. 
Galfrt, G., and C. Milstein (198 1) Preparation of monoclonal anti- 
bodies: Strategies and procedures. In Methods in Enzymology, vol. 
73, J. J. Langone and H. Van Vunakis, eds., pp. 346, Academic, 
Orlando, FL. 
Galfrt, G., S. C. Howe, C. Milstein, G. W. Butcher, and J. C. Howard 
(1977) Antibodies to major histocompatibility antigens produced by 
hybrid cell lines. Nature 266: 550-552. 
Gefter, M. L., D. H. Margulies, and M. D. Scharlf (1977) A simple 
method for polyethylene glycol-promoted hybridization of mouse 
myeloma cells. Somatic Cell Get&. 2: 23 l-236. 
Gilbert, L. I., W. E. Bollenbacher, N. Agui, N. A. Granger, B. J. Sedlak, 
D. Gibbs, and C. M. Buys (1981) The prothoracicotropes: Source 
of the prothoracicotropic hormone. Am. Zool. 21: 641-653. 
Hayes, T. K., and L. L. Keeley (1986) Isolation and structure of the 
hypertrehalosemic hormone from Bluberus discoid& cockroaches. 
In Insect Neurochemistry and Neurophysiology, A. B. Boikovec and 
D. B. Gelman. eds.. DD. 195-198. Humana. Clifton. NJ. 
Highnam, K. C.( and ‘M: W. West (1971) The neuropilar neurosecre- 
tory reservoir of Locusta migrutoriu migrutorioides, Gen. Comp. 
Endocrinol. 16: 574-585. 
Hoffmann, J. A., and M. Lagueux (1985) Endocrine aspects of em- 
bryonic development in insects. In Comprehensive Insect Physiology, 
Biochemistry and Pharmacology, vol. 1, G. A. Kerkut and L. I. Gil- 
bert, eds., pp. 435-460, Pergamon, New York. 
Hiikfelt, T., 0. Johansson, A. Ljungdahl, J. M. Lundberg, and M. 
Schultzberg (1980) Peptidergic neurons. Nature 284: 5 15-52 1. 
Holman, G. M., B. J. Cook, and R. J. Nachman (1986) Isolation, 
primary structure, and synthesis of leucomyosuppressin, an insect 
neuropeptide that inhibits spontaneous contractions of the isolated 
cockroach hindaut. Como. Biochem. Phvsiol. C 85: 329-334. 
Ishizaki, H., A. MEoguchi, M. Fujishita, A. Suzuki, I. Moriya, H. O’Oka, 
H. Kataoka, A. Isogai, H. Nagasawa, S. Tamura, and A. Suzuki (1983) 
Species specificity of the insect prothoracicotropic hormone (PTTH): 
The presence of Bombyx- and Sumiu-specific PTTHs in the brain of 
Bombyx mori. Dev. Growth Differ. 25: 593-600. 
Joosse, J. (1986) Neuropeptides: Peripheral and central messengers of 
the brain. In Comparative Endocrinology: Developments and Direc- 
tions, C. L. Ralph, ed., pp. 13-32, Liss, New York 
Amino acid sequence of eclosion hormone of the silkworm, Bombyx 
mori. Ag. Biol. Chem. 51: 2307-2308. 
Krieger, D. T. (1983) Brain peptides: What, where and why? Science 
222: 975-985. 
Littlefield, J. W. (1964) Selection of hybrids from matings of fibroblasts 
in vitro and their presumed recombinants. Science 145: 709-7 10. 
Marti, T., K. Takio, K. A. Walsh, G. Terzi, and J. W. Truman (1987) 
Microanalysis of the amino acid sequence of the eclosion hormone 
from the tobacco homworm Munducu sextu. Fed. Eur. Biochem. Sot. 
Lat. 219: 415-418. 
Mizoguchi, A., H. Ishizaki, H. Nagasawa, H. Kataoka, A. Isogai, S. 
Tamura, A. Suzuki, M. Fujino, and C. Kitada (1987) A monoclonal 
antibody against a synthetic fragment of bombyxin (4K-prothoraci- 
cotropic hormone) from the silkmoth, Bombyx mori: Characteriza- 
tion and immunohistochemistry. Mol. Cell. Endocrinol. 51: 227-235. 
Nagasawa, H., H. Kataoka, A. Isogai, S. Tamura, A. Suzuki, H. Ishizaki, 
A. Mizoguchi, Y. Fujiwara, and A. Suzuki (1984) Amino-terminal 
amino acid sequence of the silkworm prothoracicotropic hormone: 
Homology with insulin. Science 226: 1344-l 345. 
Nagasawa, H., H. Kataoka, A. Isogai, S. Tamura, A. Suzuki, A. Mi- 
zoguchi, Y. Fujiwara, A. Suzuki, S. Y. Takahashi, and H. Ishizaki 
(1986) Amino acid sequence of a prothoracicotropic hormone of the 
silkworm, Bombyx mori. Proc. Natl. Acad. Sci. USA 83: 5840-5843. 
Nijhout, H. F. (1975) Axonal pathways in the brain-retrocerebral neu- 
roendocrine complex of Munducu sextu (L.) (Lepidoptera: Sphingi- 
dae). Int. J. Insect Morphol. Embryol. 4: 529-538. 
O’Brien. M. A.. N. A. Granter. N. Aaui. L. I. Gilbert. and W. E. Bol- 
lenbacher ( 1986) Prothor&idotrop~ hormone in the developing brain 
of the tobacco homworm, Munducu sextu: Relative amounts of two 
molecular forms. J. Insect Physiol. 32: 7 19-725. 
Oi. V. T., and L. A. Herzenberg (1980) Immunoglobulin-producing 
hybrid cell lines. In Selected Methods in Cellular Immunology, B. B. 
Mishell and S. M. Shiizi. eds.. DD. 351-372. Freeman. San Francisco. 
Pontecorvo, G. (1975) Production of indefinitely multiplying mam- 
malian somatic cell hybrids by polyethylene glycol (PEG) treatment. 
Somatic Cell Genet. I: 397400. 
Purves, D., and J. W. Lichtman (1985) Principles of Neural Devel- 
opment, Sinauer, Sunderland, MA. 
Scharrer, B. (1977) Peptides in neurobiology: Historical introduction. 
In Current Topics in Neurobiology, H. Gainer, ed., pp. 1-8, Plenum, 
New York. 
Schooneveld, H. (1974) Ultrastructure of the neurosecretory system 
of the Colorado potato beetle, Leptinotursu decemlineutu (Say). Cell 
Tissue Res. 154: 289-301. 
Starratt, A. N., and B. E. Brown (1975) Structure of the pentapeptide 
nroctolin. a DrODOSed neurotransmitter in insects. Life Sci. 17: 1253- 
i256. - . 
Steel, C. G. H. (1978) Some functions of identified neurosecretory 
cells in the brain of the aphid, Megouru viciue. Gen. Comp. Endo- 
crinol. 34: 219-228. 
Stone, J. V., W. Mordue, K. E. Batley, and H. R. Morris (1976) Struc- 
ture of larval adipokinetic hormone, a neurohormone that regulates 
lipid utilization during flight. Nature 263: 207-2 11. 
Suzuki, A. (1986) Prothoracicotropic hormones and neurohormones 
in Bombyx mori. In Insect Neurochemistry and Neurophysiology, A. 
B. Boikovec and D. B. Gelman, eds., pp. 29-5 1, Humana, Clifton, 
NJ. 
Kataoka, H., H. Nagasawa, A. Isogai, S. Tamura, A. Mizoguchi, Y. 
Fujiwara, C. Suzuki, H. Ishizaki, and A. Suzuki (1987) Isolation 
and partial characterization of a prothoracicotropic hormone of the 
silkworm, Bombyx mori. Agr. Biol. Chem. 51: 1067-1076. 
Keamey, J. F., A. Radbruch, B. Liesegang, and K. Rajewsky (1979) 
A new mouse myeloma cell line that has lost immunoglobulin expres- 
sion but permits the construction of antibody-secreting hybrid cell 
lines. J. Immunol. 123: 1548-1550. 
Kiihler, G., and C. Milstein (1975) Continuous cultures of fused cells 
secreting antibody of predefined specificity. Nature 256: 495-497. 
Kono, T., H. Nagasawa, A. Isogai, H. Fugo, and A. Suzuki (1987) 
Taghert, P. H. (1981) Identification and analysis of neurosecretory 
neurons in an insect. In Neurosecretion: Molecules, Cells, Systems, 
D.S. Famer and K. Lederis, eds., pp. 456457, Plenum, New York. 
Taghert, P. H., and J. W. Truman (1982) Identification ofthe bursicon- 
containing neurones in abdominal ganglia of the tobacco homworm, 
Munducu sextu. J. Exp. Biol. 98: 385-401. 
Tublitz, N. J., and J. W. Truman (1985) Identification of the neurones 
containing cardioacceleratory peptides (CAPS) in the ventral nerve 
cord of the tobacco hawkmoth, Munducu sexta. J. Exp. Biol. 116: 
395-410. 
